SELLAS Life Sciences Group, Inc. (SLS) Balance sheet

Market cap

$552.77M

P/E ratio

	2011/12	2012/12	2013/12	2014/12	2015/12	2016/12	2017/12	2018/12	2019/12	2020/12	2021/12	2022/12	2023/12	2024/12
Cash and cash equivalents	11	33	48	24	30	18	2	5	7	35	21	17	3	14
Total cash & short-term investments	11	33	48	24	30	18	2	5	7	35	21	17	3	14
Accounts receivable, net	-	-	4	2	-	-	-	-	-	-	-	-	-	-
Inventories	-	-	0	1	-	-	-	-	-	-	-	-	-	-
Total current assets	12	36	53	29	54	37	13	6	8	37	23	18	3	16
Property, plant and equipment, net	0	0	1	1	0	0	-	-	-	-	-	-	-	-
Total non-current assets	19	19	35	51	29	28	20	11	8	9	3	3	3	3
Total assets	31	55	88	80	82	66	34	17	17	46	26	21	6	19
Accounts payable	2	2	3	2	2	1	12	4	4	5	2	3	6	4
Long-term debt, current	-	-	2	4	5	16	8	-	-	-	-	-	-	-
Total current liabilities	11	16	62	27	57	30	25	6	5	12	5	16	14	10
Long-term debt, non-current	-	-	8	4	-	-	3	-	-	-	-	-	-	-
Total non-current liabilities	10	11	20	16	12	7	7	6	5	6	1	1	0	0
Total liabilities	21	27	82	43	69	37	31	12	11	18	6	16	14	10
Common stock and paid-in capital	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Retained earnings	-	-	-	-	-	-	-54	-82	-101	-118	-139	-180	-217	-248
Stockholders' equity	10	28	6	37	14	29	2	5	6	28	20	5	-8	9
Total debt	-	-	10	8	5	16	11	-	-	-	-	-	-	-
Net debt	-	-	-38	-15	-25	-2	9	-5	-	-	-	-	-	-
D/E ratio (%)	-	-	168.1	22.7	35.1	57.2	530.8	-	-	-	-	-	-	-
Working capital	-	-			-	-	-	-	-	-	-	-	-	-